A theoretical analysis of interval drug dosing for cell-cycle-phase- specific drugs
From MaRDI portal
Publication:1193125
DOI10.1016/0025-5564(92)90053-YzbMath0746.92012OpenAlexW2072119474WikidataQ46308140 ScholiaQ46308140MaRDI QIDQ1193125
Publication date: 27 September 1992
Published in: Mathematical Biosciences (Search for Journal in Brave)
Full work available at URL: https://doi.org/10.1016/0025-5564(92)90053-y
zidovudinecancer drugsproliferation ratecytosine arabinosideAIDS drugsara-Caverage cycle time of the host susceptible cellsAZTcell-cycle-phase-specific drugsdrug toxicitydrug-susceptible life phaseduration of the dosing intervallife-cycle parameters
Kinetics in biochemical problems (pharmacokinetics, enzyme kinetics, etc.) (92C45) Medical applications (general) (92C50)
Related Items
Personalized drug administration for cancer treatment using model reference adaptive control, A mathematical model of cycle-specific chemotherapy, A model for treatment strategy in the chemotherapy of AIDS, A mathematical model of periodically pulsed chemotherapy: Tumor recurrence and metastasis in a competitive environment, Stochastic modeling of drug resistance in cancer, A microenvironment based model of antimitotic therapy of Gompertzian tumor growth, A mathematical model for the effects of HER2 over-expression on cell cycle progression in breast cancer, Analysis of resonance chemotherapy in leukemia treatment via multi-staged population balance models, Optimal policies of non-cross-resistant chemotherapy on Goldie and Coldman's cancer model, Chemotherapy of vascularised tumours: role of vessel density and the effect of vascular ``pruning, Optimisation of time-scheduled regimen for anti-cancer drug infusion, A mathematical model of in vitro cancer cell growth and treatment with the antimitotic agent curacin \(A\), USING COMPUTER SIMULATIONS FOR EVALUATING THE EFFICACY OF BREAST CANCER CHEMOTHERAPY PROTOCOLS, A mathematical model to study the effects of drugs administration on tumor growth dynamics, Intensified Doxorubicin-Based Regimen Efficacy in Residual Non-Hodgkin's Lymphoma Disease: Towards a Computationally Supported Treatment Improvement, Modelling acidosis and the cell cycle in multicellular tumour spheroids, Optimal controls for a model with pharmacokinetics maximizing bone marrow in cancer chemo\-therapy, LONG-RANGE PREDICTABILITY IN MODELS OF CELL POPULATIONS SUBJECTED TO PHASE-SPECIFIC DRUGS: GROWTH-RATE APPROXIMATION USING PROPERTIES OF POSITIVE COMPACT OPERATORS, Mixed therapy in cancer treatment for personalized drug administration using model reference adaptive control, Mathematical modelling of drug transport in tumour multicell spheroids and monolayer cultures
Cites Work
